Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

Finasteride effectively promotes hair growth and reduces hair loss in men with androgenetic alopecia.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

More plasma leptin means higher baldness risk in men.

Hair loss is common in IBD patients, and some medications may lower the risk.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Sh-Polypeptide 9 may be better than minoxidil for hair growth and protection against damage.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

Spironolactone might lower the chance of getting rosacea.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Clinicians should recognize taste disorders and hair loss as important symptoms in myasthenia gravis patients.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Severe hair loss links to metabolic issues in older men with psoriasis.